Individuals with schizophrenia and related disorders experience significant functioning deficits in the community. The study of social cognition in schizophrenia has grown rapidly over the past decade, and a consensus has developed among researchers that dysfunction in social cognition may contribute to the severe interpersonal problems that are a hallmark of schizophrenia. This has generated hope that treatments which improve social cognition in this illness may enhance an individual's ability to live a socially engaged and rewarding life. Social Cognition in Schizophrenia: From Evidence to Treatment provides a firm grounding in the theory and research of normal social cognition, builds on this base to describe how social cognition appears to be dysfunctional in schizophrenia, and explains how this dysfunction might be ameliorated. Composed of contributed chapters written by the top experts in the field, the volume is divided into three parts to address each of these areas. Part I, Foundations of Human Social Cognition, explores normal social cognition in childhood development, adulthood, and across cultures, as well the brain-bases of social cognition and clinical social cognition research. Part II, Social Cognition in Schizophrenia: Descriptive and Experimental Research, discusses social cognition and functional outcome, emotion processing, Theory of Mind, paranoid ideation, social cognition in early psychosis, and the social cognitive neuroscience of schizophrenia. Part III, Social Cognition in Schizophrenia: Treatment Approaches, focuses on findings from current treatment outcome research as well as several leading social cognitive intervention approaches-Integrated Neurocognitive Therapy (INT), Cognitive Enhancement Therapy (CET), Metacognitive Training (MCT), and Social Cognition and Interaction Training (SCIT). This comprehensive, accessible volume will be invaluable to researchers studying social cognition and psychosocial treatment development in schizophrenia, clinicians working with this patient population, students in social and clinical psychology, nursing, social work and occupational therapy, and medical students.

The first book in a new series from the World Psychiatric Association, Schizophrenia: current science and clinical practice presents recent information on the diagnosis, neurobiological foundations, and management of schizophrenia. It evaluates the findings obtained with modern techniques like magnetic resonance imaging, genetics and network analyses. The book reviews the importance of neurocognitive functioning in schizophrenia and its predictive value for functional capacity. It covers the key areas of early recognition, prevention, rehabilitation and stigma. There is also a critical discussion of diagnostic classification and the revision of the two major international systems. Written by experts in the field who have a track record of being engaging authors, this book provides a rapid overview of the current state of the art in schizophrenia research and clinical management. It will be invaluable to all psychiatrists, psychologists, neuropharmacologists, researchers in psychiatry and psychopharmacology in academia and in industry, and clinical and behavioural neuroscientists.

Cognitive-behavioral treatment of obsessive compulsive disorder / Martin E. Franklin, Edna B. Foa -- Pharmacological treatment of obsessive compulsive disorder / Darin D. Dougherty, Scott L. Rauch, Michael A. Jenike -- Psychopharmacological treatment of post-traumatic stress disorder / Julia A. Golier ... [et al.] -- Psychosocial treatments for posttraumatic stress disorder / Lisa M. Najavits -- Psychotherapy and pharmacotherapy for sexual dysfunctions / Emmanuelle Duterte, Taylor Segraves, Stanley Althof -- Treatments for pathological gambling and other impulse control disorders / Jon E. Grant, Marc N. Potenza -- Treatment of eating disorders / G. Terence. Wilson, Christopher G. Fairburn -- Treatments for insomnia and restless legs syndrome / Douglas E. Moul ... [et al.] -- Psychological treatments for personality disorders / Paul Crits-christoph, Jacques P. Barber -- Psychopharmacological treatment of personality disorders / Harold W. Koenigsberg, Ann Marie Woo-ming, Larry J. Siever -- Combination pharmacotherapy and psychotherapy for the treatment of major depressive and anxiety disorders / Cindy J. Aaronson, Gary P. Katzman, Jack M. Gorman

Schizophrenia remains an enigma to many clinicians, despite recent progress in the scientific understanding of its causes, symptoms and potential treatments. Whilst the DSM-IV and ICD-10 classification systems have provided a reasonably reliable set of diagnostic criteria for 'schizophrenia', the validity of the construct remains elusive, and clinicians and researchers need to be wary about accepting these as definitive. Indeed schizophrenia remains a clinical diagnosis, based on certain signs and symptoms, and none of these is pathognomonic; there is also no laboratory or radiological test for the condition. Part of the Oxford Psychiatry Library, this pocketbook provides well-balanced answers to common questions about schizophrenia. Part 1 covers classification, clinical features, epidemiology, aetiological factors, brain abnormalities, and neurochemistry. Part 2 focuses on management and covers service models, and biological, psychological and social aspects of treatment. Part 3 includes patient/carer information on medications used in psychiatry, tips about dealing with side effects and enhancing adherence, and information about looking after physical health. This pocketbook will serve as a concise useful guide for psychiatrists, trainees, specialist nurses and interested general practitioners.

An international team of leading researchers and clinicians here provide a comprehensive, epidemiological overview of this multi-faceted and still perplexing disorder, and address some of the key questions it raises. How important in the genetic contribution to schizophrenia? Do pregnancy and birth complications increase the risk for schizophrenia? Is the incidence of schizophrenia changing? Why is the rate higher among immigrants and in those born in cities? Controversial issues such as the validity of discrete or dimensional classifications of schizophrenia and the continuum between psychosis and 'normality' are explored in depth, and separate chapters are devoted to topics of particular relevance to schizophrenia such as suicide, violence and substance abuse. Finally, new prospects for treatment and prevention are considered. Drawing together the findings from social, genetic, developmental and classical epidemiology of schizophrenia, this text will prove an invaluable resource for clinicians and researchers.

The body of knowledge that we have accumulated about the causes and nature of schizophrenia is prodigious, and the repertoire of evidence-based treatments is substantial and increasing. Comprehensive Care of Schizophrenia distills this corpus into the essential information that clinicians who care for persons with schizophrenia need to know. The second edition of the popular volume is thoroughly updated, offering new information on the advances in research and management since the first edition was published a decade ago. Chapters are streamlined to keep content as concise as possible, while key sections have been revised and expanded to include new information on drug therapy and advice on patient care. People with schizophrenia can suffer from multiple morbidities and disabilities, and thus may require a variety of treatments, both pharmacological and psychosocial. To cover the complex and growing field of schizophrenia management, renowned psychiatrists Jeffrey Lieberman and Robin Murray have recruited a distinguished group of researchers, practitioners and consumers of mental health care. This guide delves into to all aspects of the clinical management of schizophrenia for both the health care professional who treats patients as well as the researcher interested in the advances made in the field and their clinical application.